Seeking Alpha

Theseus Pharmaceuticals Initial Dose Escalation Results from Ongoing Phase 1/2 Trial of THE ...

CAMBRIDGE, Mass., April 26, 2023 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the lives of cancer ...
Seeking Alpha

Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for ...

CAMBRIDGE, Mass., Dec. 22, 2023 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (THRX) ("Theseus" or the "Company"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer ...